Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment
Background: We evaluated the impact of prior statin use on successful reperfusion and stroke outcomes after endovascular treatment (EVT). Method: Using consecutive multicenter databases, we enrolled acute ischemic stroke patients receiving EVT between 2015 and 2021. Patients were classified into pri...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
MDPI AG
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/516a0381786148aab2a26e0fa3784fa7 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:516a0381786148aab2a26e0fa3784fa7 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:516a0381786148aab2a26e0fa3784fa72021-11-11T17:46:20ZImpact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment10.3390/jcm102151472077-0383https://doaj.org/article/516a0381786148aab2a26e0fa3784fa72021-11-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/5147https://doaj.org/toc/2077-0383Background: We evaluated the impact of prior statin use on successful reperfusion and stroke outcomes after endovascular treatment (EVT). Method: Using consecutive multicenter databases, we enrolled acute ischemic stroke patients receiving EVT between 2015 and 2021. Patients were classified into prior statin users and no prior statin users after a review of premorbid medications. The primary outcome measure was successful reperfusion defined as modified TICI grade 2b or 3 after EVT. Secondary outcome measures were early neurologic deterioration (END) and a 3-month modified Rankin Scale (mRS) score of 0 to 2. Results: Among 385 patients receiving EVT, 74 (19.2%) were prior statin users, who had a significantly higher successful reperfusion rate compared with no prior statin users (94.6% versus 78.8%, <i>p</i> = 0.002). Successful reperfusion and END occurrence were improved according to statin intensity with a dose–response relationship. In multivariate analysis, prior statin was associated with successful reperfusion after EVT (adjusted odds ratio (95% confidence interval) 5.31 (1.67–16.86)). In addition, prior statin was associated with a lower occurrence of END and good functional status. Conclusion: Our study showed that prior statin use before ischemic stroke might improve successful reperfusion and stroke outcomes after EVT.Sang-Hwa LeeMin Uk JangYerim KimSo Young ParkChulho KimYeo Jin KimJong-Hee SohnMDPI AGarticleprior statinendovascular treatmentreperfusion rateearly neurologic deteriorationstroke outcomeMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5147, p 5147 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
prior statin endovascular treatment reperfusion rate early neurologic deterioration stroke outcome Medicine R |
| spellingShingle |
prior statin endovascular treatment reperfusion rate early neurologic deterioration stroke outcome Medicine R Sang-Hwa Lee Min Uk Jang Yerim Kim So Young Park Chulho Kim Yeo Jin Kim Jong-Hee Sohn Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment |
| description |
Background: We evaluated the impact of prior statin use on successful reperfusion and stroke outcomes after endovascular treatment (EVT). Method: Using consecutive multicenter databases, we enrolled acute ischemic stroke patients receiving EVT between 2015 and 2021. Patients were classified into prior statin users and no prior statin users after a review of premorbid medications. The primary outcome measure was successful reperfusion defined as modified TICI grade 2b or 3 after EVT. Secondary outcome measures were early neurologic deterioration (END) and a 3-month modified Rankin Scale (mRS) score of 0 to 2. Results: Among 385 patients receiving EVT, 74 (19.2%) were prior statin users, who had a significantly higher successful reperfusion rate compared with no prior statin users (94.6% versus 78.8%, <i>p</i> = 0.002). Successful reperfusion and END occurrence were improved according to statin intensity with a dose–response relationship. In multivariate analysis, prior statin was associated with successful reperfusion after EVT (adjusted odds ratio (95% confidence interval) 5.31 (1.67–16.86)). In addition, prior statin was associated with a lower occurrence of END and good functional status. Conclusion: Our study showed that prior statin use before ischemic stroke might improve successful reperfusion and stroke outcomes after EVT. |
| format |
article |
| author |
Sang-Hwa Lee Min Uk Jang Yerim Kim So Young Park Chulho Kim Yeo Jin Kim Jong-Hee Sohn |
| author_facet |
Sang-Hwa Lee Min Uk Jang Yerim Kim So Young Park Chulho Kim Yeo Jin Kim Jong-Hee Sohn |
| author_sort |
Sang-Hwa Lee |
| title |
Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment |
| title_short |
Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment |
| title_full |
Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment |
| title_fullStr |
Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment |
| title_full_unstemmed |
Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment |
| title_sort |
impact of prior statin use on reperfusion rate and stroke outcomes in patients receiving endovascular treatment |
| publisher |
MDPI AG |
| publishDate |
2021 |
| url |
https://doaj.org/article/516a0381786148aab2a26e0fa3784fa7 |
| work_keys_str_mv |
AT sanghwalee impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment AT minukjang impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment AT yerimkim impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment AT soyoungpark impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment AT chulhokim impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment AT yeojinkim impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment AT jongheesohn impactofpriorstatinuseonreperfusionrateandstrokeoutcomesinpatientsreceivingendovasculartreatment |
| _version_ |
1718431999971033088 |